Sat.
Jul 2
2022

Italy’s medicines agency approves J&J’s COVID-19 vaccine

Reuters
Mar 12, 2021
MILAN (Reuters) – Italy’s medicines agency AIFA said on Friday it has approved the use of the COVID-19 vaccine produced by Johnson & Johnson, following the green light from European drugs regulator (EMA) on Thursday.
The vaccine is the fourth to be endorsed for use in the European Union after vaccines from Pfizer-BioNTech,, AstraZeneca-Oxford University and Moderna, and is recommended for those over 18 years of age. It’s the first single-dose COVID-19 vaccine.
“This is the fourth vaccine to be available with the important additional advantage of a single dose and ease of administration, therefore ideal for the setting of family doctors. From mid-April, an important reality,” said AIFA’s general director Nicola Magrini in the agency’s website.
The Italian agency said it confirmed the EMA’s assessment of the vaccine’s efficacy, which reaches up to 77% 14 days after administration and 85% 28 days after administration.
Reuters
This website uses cookies to improve and customize the user experience. To learn more, please see our cookie policy.
Cookie Policy
WP Twitter Auto Publish Powered By : XYZScripts.com